Product Reports Resources Pricing Login Book a demo

DXY

Biotech & Life Sciences · Dongcheng District, China · Founded 2000

DXY.cn is a Chinese healthcare startup that operates a comprehensive online platform catering to medical professionals and health-conscious individuals. The company provides a suite of digital tools and resources through its website and mobile apps, available on both iOS and Android. DXY.cn serves a diverse client base, including doctors, researchers, and general users interested in health and wellness. The market DXY.cn operates in is the digital healthcare sector, which is rapidly growing due to increasing demand for accessible medical information and services. The platform offers a variety of features such as medical news, research articles, professional networking opportunities, and health management tools. It also includes specialized content on topics like RNA, AI in healthcare, and PCR (a method used in molecular biology to amplify DNA sequences). DXY.cn's business model revolves around providing valuable content and services to its users. The company generates revenue through multiple streams, including subscription fees for premium content, advertising, and partnerships with pharmaceutical companies and healthcare providers. By offering a mix of free and paid services, DXY.cn attracts a broad audience while monetizing its more advanced features and specialized content. In summary, DXY.cn is a key player in the digital healthcare market in China, offering a robust platform for medical professionals and health enthusiasts. Its diverse revenue streams and comprehensive service offerings position it well for continued growth in the rapidly evolving healthcare landscape. Keywords: digital healthcare, medical professionals, health management, research articles, professional networking, subscription fees, advertising, pharmaceutical partnerships, iOS, Android.

Investors

6 investors on DXY's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage
Series A 2 investors entered at this stage
Series B+ 3 investors entered at this stage
Tencent
Trustbridge Partners
Hillhouse Capital

Global footprint

Where DXY has talent and traffic

Workforce by country
🇨🇳 China · Dongcheng District HQ
Book a demo for the full country breakdown

Talent graph

The shape of DXY's talent

Dealroom maps DXY's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

5 team members profilednamed & role-tagged by Dealroom
185 employeestotal headcount
4 executives & foundersidentified by name
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock DXY's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$338k patent portfolio · 10 active families

Estimated portfolio value
$338k
0.01% of valuation · 872.3× smaller than top peer Verily ($295M)
10 active patent families

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about DXY

An AI-synthesized read of the highest-engagement posts about DXY on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See DXY on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.